NCT06683066 2024-11-12
Study on Human Bioequivalence of Triprerelin Acetate for Injection
The Affiliated Hospital of Qingdao University
Phase 1 Recruiting
Clinical Trials
9 trialsNCT06282588 2024-02-28
THUNDER
Cancer Research Antwerp
Phase 2/3 Recruiting
NCT03709550 2022-10-05
Enzalutamide and Decitabine in Treating Patients With Metastatic Castration Resistant Prostate Cancer
Roswell Park Cancer Institute
Phase 1/2 Withdrawn
NCT04272645 2020-07-15
Abemaciclib With or Without Atezolizumab in Metastatic Castration Resistant Prostate Cancer
University of Michigan Rogel Cancer Center
Phase 2 Withdrawn
NCT02647983 2020-01-22
Multiparametric MRI for Prostate Cancer Localization and Characterization Using Hyperpolarized Pyruvate (13C) Injection
Sunnybrook Health Sciences Centre
Phase 1 Withdrawn
NCT02584400 2019-03-08
HX4 SD
Maastricht Radiation Oncology
Phase 2 Terminated
NCT01993160 2017-01-13
18F-FCH (Fluorocholine)-PET/MR in Staging of High-Risk Prostate Cancer
University Health Network, Toronto
Phase NA Completed
NCT01481441 2016-07-06
AMC_2011_190
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Phase NA Terminated
NCT01229618 2015-10-05
Hyperpolarized Pyruvate Injection in Subjects With Prostate Cancer
University of California, San Francisco
Phase 1 Completed